HealthData.Gov
Anti-atherogenic effects of fibrates in type 2 diabetes
Type 2 diabetes is an increasing cause of premature coronary heart disease. Several trials with lipid-modifying therapy have included sufficient numbers of diabetics to indicate that treatment of diabetic dyslipidaemia…
- HTML
Updated Oct 29, 2026